KYTHERA BIOPHARMACEUTICALS I's ticker is KYTH and the CUSIP is 501570105. A total of 104 filers reported holding KYTHERA BIOPHARMACEUTICALS I in Q2 2014. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $1,252,000 | -31.3% | 16,700 | -31.0% | 0.01% | -14.3% |
| Q2 2015 | $1,823,000 | +43.9% | 24,200 | -4.2% | 0.01% | +40.0% |
| Q1 2015 | $1,267,000 | +176.0% | 25,256 | +90.9% | 0.01% | +150.0% |
| Q4 2014 | $459,000 | +4.8% | 13,233 | -1.1% | 0.00% | 0.0% |
| Q3 2014 | $438,000 | -14.5% | 13,382 | +0.4% | 0.00% | 0.0% |
| Q2 2014 | $512,000 | +42.2% | 13,331 | +47.1% | 0.00% | 0.0% |
| Q1 2014 | $360,000 | -20.4% | 9,062 | -25.3% | 0.00% | 0.0% |
| Q4 2013 | $452,000 | -11.0% | 12,126 | +9.0% | 0.00% | 0.0% |
| Q3 2013 | $508,000 | +245.6% | 11,126 | +104.4% | 0.00% | +100.0% |
| Q2 2013 | $147,000 | – | 5,444 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 1,382,722 | $69,344,000 | 3.43% |
| Versant Venture Management, LLC | 70,376 | $3,529,356,000 | 3.10% |
| AlpInvest Partners B.V. | 29,731 | $1,491,000 | 2.79% |
| Partner Investment Management, L.P. | 29,178 | $1,463,000 | 2.20% |
| PFM Health Sciences, LP | 1,242,509 | $62,312,000 | 1.72% |
| Aureus Asset Management, LLC | 130,307 | $6,535,000 | 1.50% |
| BRIDGER MANAGEMENT, LLC | 444,999 | $22,317,000 | 1.49% |
| HealthCor Management, L.P. | 425,000 | $21,314,000 | 1.02% |
| Redmile Group, LLC | 225,062 | $11,287,000 | 1.01% |
| REGENTATLANTIC CAPITAL LLC | 174,454 | $8,749,000 | 0.77% |